When a Boston business needs a securities lawyer
Four moments typically send Boston companies to securities counsel. You're raising private capital under Reg D and need a PPM and Form D filed. You're going public and need an S-1 drafted, a road show planned, and underwriter counsel coordinated. You're already public and need help with a 10-K, an 8-K event disclosure, a proxy, or a stock plan amendment. Or you just received a document subpoena, exam letter, or Wells notice from the SEC's Boston Regional Office at 33 Arch Street.
Boston's securities market is concentrated around two industries the city dominates nationally: life sciences and asset management. Cambridge biotech IPOs alone account for a meaningful share of all U.S. life-sciences listings in any given year, and the Boston-area mutual-fund and registered-investment-adviser community manages trillions in assets. Goodwin, Ropes & Gray, WilmerHale, Mintz, Foley Hoag, and Latham & Watkins handle the bulk of senior capital-markets and enforcement work; Sullivan & Worcester, Choate Hall & Stewart, and Nutter McClennen round out the middle of the market.
Boston-specific securities issues you'll likely encounter:
- SEC Boston Regional Office enforcement focus on biotech disclosure — clinical-trial results, regulatory communications, manufacturing setbacks, and Reg FD around FDA catalysts
- Massachusetts blue-sky notice filings under M.G.L. c. 110A and Form D filings with the Secretary of the Commonwealth's Securities Division
- Investment Adviser Act registration with the SEC (or MA state registration for advisers under $100M AUM)
- Mutual fund and ETF formation work under the 1940 Act — Boston is home to Fidelity, MFS, Putnam, State Street, and Wellington
- SPAC formation, redemption work, and de-SPAC business combinations
- Insider-trading review around clinical milestones, M&A rumors, and earnings windows
- Section 11 IPO litigation in the District of Massachusetts and shareholder derivative suits
- Massachusetts Uniform Securities Act actions brought by the Secretary's office
- Galvin's office investigations of unregistered offerings, broker-dealer misconduct, and adviser breaches
Firms in Boston that handle securities work
1
★★★★★
Chambers Band 1 · Capital Markets & Securities Litigation MA
Hourly
Boston-rooted full-service firm with one of the deepest capital-markets and securities-litigation benches in Massachusetts. Particularly dominant for life sciences IPOs and follow-on offerings out of Cambridge and the Seaport, asset management regulatory work for Boston-headquartered mutual fund complexes, and SEC enforcement defense before the Boston Regional Office. Headquartered at Prudential Tower.
Chambers Band 1
$1,150–$2,150/hr
Life Sciences + Asset Management
800 Boylston St, Boston
2
★★★★★
Best Law Firms Tier 1 · Securities Litigation Boston
Hourly
Goodwin is the firm most regularly named on Boston-area biotech and tech IPOs, with capital-markets attorneys embedded in the same corporate group that runs the city's life sciences M&A practice. Particularly strong on emerging growth IPOs, PIPE financings, and ATM offerings for already-public Cambridge therapeutics companies. SEC enforcement and securities-class-action defense out of the same Seaport office.
Best Law Firms Tier 1
$1,100–$1,950/hr
Biotech IPOs + PIPEs
100 Northern Ave, Boston
3
★★★★★
Chambers-ranked · Securities Regulation USA + MA
Hourly
Originally Hale and Dorr, WilmerHale's Boston roots are a century deep and its securities-enforcement practice is one of the most senior in the country, with multiple former SEC senior staff. Particularly suited for SEC investigations and Wells responses out of the Boston Regional Office, internal investigations triggered by whistleblower complaints, and shareholder class actions defending Boston-area public companies.
Chambers-ranked
$1,150–$2,100/hr
SEC Enforcement Defense
60 State St, Boston
4
★★★★★
Chambers-ranked · Capital Markets Massachusetts
Hourly
Boston-headquartered firm at One Financial Center with a securities and capital-markets practice that regularly handles emerging growth IPOs, SPAC transactions, and PIPE financings. Particularly well-suited to mid-cap life sciences and tech issuers who want a Boston firm without paying New York rates. Active in SEC enforcement matters and Massachusetts blue-sky compliance for advisers under $100M AUM.
Chambers-ranked Capital Markets
$725–$1,500/hr
SPACs + Emerging Growth IPOs
One Financial Center, Boston
5
★★★★★
Chambers Band 1 · Capital Markets MA
Hourly
Global firm with a Boston office focused heavily on biotechnology and pharmaceutical capital-markets work. Particularly known for representing global investment banks as underwriters on Boston-area biotech IPOs and follow-on offerings, plus large-cap public-company issuers on debt offerings and exchange listings. Best fit when the deal sits at $300M+ and the syndicate is bulge-bracket.
Chambers Band 1
$1,250–$2,200/hr
Biotech IPOs + Debt Offerings
200 Clarendon St, Boston
What Boston securities work typically costs
$725–$2,200/hr
Partner billing range
$1.5M–$3.5M
First-time IPO through pricing
$35k–$95k
Reg D private placement
$250k–$2M+
SEC enforcement defense
Boston BigLaw partners on securities work bill $1,100–$2,200/hr. Senior associates run $725–$1,250/hr. Mid-market firms (Mintz, Foley Hoag, Nutter, Choate, Sullivan & Worcester) come in at $625–$1,150/hr at the partner level, often a meaningful saving on Reg D placements, 10-Q quarterly filings, and 8-K disclosure work where senior partner involvement is lighter.
A first-time Boston IPO at a top firm typically runs $1.5M–$3.5M in legal fees from organizational meeting through pricing. Year-one public-company counsel adds another $250,000–$500,000. A typical Reg D private placement comes in at $35,000–$95,000. A SPAC IPO is in the $500,000–$1.2M range. SEC enforcement defense usually starts at $250,000–$750,000 just for the investigation phase, and contested matters that go to administrative or federal court routinely exceed $2M before settlement or trial.
For investment adviser registration (Form ADV, compliance manual, Code of Ethics), expect $25,000–$65,000 for a first-time SEC-registered adviser. Massachusetts state-registered advisers run lower. Annual compliance support typically lands at $35,000–$120,000/year depending on AUM and trading complexity.
Typical turnaround in Boston
- Reg D placement: 3–6 weeks from engagement to first close, including PPM drafting, accreditation verification, Form D filing.
- IPO: 5–9 months from organizational meeting to listing. S-1 drafting 6–10 weeks. First SEC comment letter ~28 days after filing. Two to four comment rounds. Roadshow plus pricing 10–15 days.
- Follow-on offering: 3–6 weeks for a seasoned issuer; same-day for shelf takedowns off an effective S-3.
- SEC subpoena response: initial document production usually due in 30–45 days; full investigation runs 12–24 months before charging decision.
- Wells notice to Wells submission: 30 days standard, with extensions possible. Settlement negotiations can run another 6–12 months.
- 10b-5 class action: motion to dismiss decided 9–14 months after filing; full case 2–4 years to trial or settlement.
Boston Securities Lawyers — FAQ
What does a Boston securities lawyer actually do?
Three core jobs. First, capital raises — IPOs, follow-on offerings, PIPEs, convertible notes, and Reg D/Reg A private placements for Boston-area life sciences, fintech, and tech companies. Second, public-company reporting — 10-K and 10-Q drafting, 8-K event disclosure, proxy statements, Section 16 filings, and Sarbanes-Oxley compliance. Third, SEC enforcement defense — responding to subpoenas, Wells notices, and formal investigations from the SEC's Boston Regional Office at 33 Arch Street.
How much do securities lawyers cost in Boston?
Boston BigLaw partners on securities work bill $1,100–$2,200/hr; senior associates $725–$1,250/hr. A first-time IPO at a Boston firm runs $1.5M–$3.5M in legal fees through pricing, with another $250k–$500k for ongoing public-company counsel in year one. A typical Reg D private placement runs $35,000–$95,000. SEC enforcement defense often starts at $250k–$750k for the investigation phase, and contested matters routinely exceed $2M.
What is the SEC's Boston Regional Office and when does it matter?
The Boston Regional Office (BRO) is one of 11 SEC regional offices, covering Massachusetts, Maine, New Hampshire, Vermont, Rhode Island, and Connecticut. It runs enforcement investigations and exams of broker-dealers, investment advisers, and public companies in the region. If you receive a Form 1662 or document subpoena from the BRO, retain experienced securities counsel before responding — even informally.
My Boston biotech got a Wells notice. What happens next?
A Wells notice tells you the SEC staff plans to recommend an enforcement action. You typically have 30 days to submit a Wells submission arguing why charges should not be brought. Boston life sciences companies most often see Wells notices on revenue recognition, clinical-trial disclosure, Reg FD violations, and insider trading around catalyst events. Wells submissions are part legal brief, part regulatory negotiation; do not draft one without securities enforcement counsel.
How long does a Boston IPO take from start to finish?
Plan for 5–9 months from organizational meeting to listing. Drafting the S-1 takes 6–10 weeks. First SEC comment letter usually arrives 28 days after initial filing. Comment rounds typically run two to four cycles. Roadshow plus pricing adds another 10–15 days. Life sciences IPOs out of Cambridge and the Seaport often run on the longer end because of complex IP, FDA, and clinical disclosure work.
What Massachusetts blue-sky issues should I expect?
NSMIA preempts state registration for most public offerings, but Massachusetts still requires notice filings and fees with the Securities Division of the Secretary of the Commonwealth for Reg D Rule 506 offerings (Form D plus a $300–$500 fee). The Massachusetts Uniform Securities Act (M.G.L. c. 110A) still applies to non-covered offerings and to investment-adviser and broker-dealer registration. Massachusetts also has an active anti-fraud regime under Galvin's office that prosecutes its own enforcement matters.
What's the difference between securities litigation and SEC enforcement defense?
Securities litigation usually means private civil actions — shareholder class actions under Rule 10b-5, derivative suits, Section 11 cases challenging IPO disclosures, and merger-objection litigation. SEC enforcement is government action — subpoenas, Wells notices, administrative proceedings, federal court suits, and parallel DOJ criminal referrals. Boston firms like WilmerHale, Goodwin, and Ropes & Gray handle both; the staffing and strategy differ significantly.
Can I use my Boston M&A firm for securities work?
Often yes. Most Boston full-service firms (Ropes & Gray, Goodwin, Mintz, WilmerHale, Foley Hoag, Choate, Nutter) staff M&A and securities out of the same corporate group. If your transaction is a public-company merger, the same team usually handles the proxy and 14A disclosure. For pure SEC enforcement defense, lead counsel often shifts to the firm's white-collar or securities-enforcement group inside the same firm.